Olo01 0003 01
Olopatadine
Product Images NDC 17478-105
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olopatadine (NDC 17478-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Olo01 0003 02
OLPTAL Rev.01/17 is an ophthalmic solution containing Olopatadine HCI used only in the eyes. It comes with 1.1mg of active Olopatadine HCI, equivalent to Olopatadine 1 mg, along with other inactive elements like Dibasic Sodium Phosphate, Sodium Chloride, and Water for Injection. The solution has Benzalkonium Chloride 0.01% as a preservative with NDC 17478-105-05 label. The appropriate storage condition is at 4° 1025°C. The usual dosage is not mentioned. The manufacturer of OLPTAL is Akorn, Inc. based in Lake Forest, IL 60045.*
Olo01 0003 03
This appears to be a description of a prescription medication called "Olopatadine". The medication is an ophthalmic solution used for the eyes and comes in a 5mL bottle. Each mL of the solution contains 1.1mg of Olopatadine hydrochloride. The medication also contains inactive ingredients such as sodium phosphate, sodium chloride, hydrochloric acid, and water for injection. The warning advises patients not to touch the solution as it may contaminate it. It is not child-resistant and should be kept out of reach of children. The manufacturer is Akorn, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
